NCT01587001View on ClinicalTrials.gov

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Pulmonary Sarcoidosis
Interventions
DIETARY_SUPPLEMENT

N-acetyl-cysteine

900mg three times daily for 8 weeks

DRUG

Placebo

Matching placebo three times daily for 8 weeks.

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

American Thoracic Society

OTHER

lead

National Jewish Health

OTHER

NCT01587001 - The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis | Biotech Hunter | Biotech Hunter